 |
 |

The Validity of DSM-III-R Hypochondriasis
Russell Noyes, Jr, MD;
Roger G. Kathol, MD;
Mary M. Fisher, MSW;
Brenda M. Phillips, MD;
Michael T. Suelzer, PhD;
Craig S. Holt, PhD
Arch Gen Psychiatry. 1993;50(12):961-970.
Abstract
Background Because of the uncertainty about the status of hypochondriasis, the disorder is rarely diagnosed. To address this problem we examined the validity of DSM-III-R hypochondriasis as identified by structured interview.
Methods Patients in a general medicine clinic were screened for hypochondriacal attitudes and symptoms. Those patients who scored above an established cutoff had a structured diagnostic interview, and 50 patients who met DSM-III-R criteria for hypochondriasis and 50 age- and sex-matched controls were thus identified. Information was obtained from both groups on health perceptions, health care utilization, and level of functioning using self-report and physician-rated measures. Additional information on diagnoses and treatment recommendations was obtained from record audits.
Results Clinic physicians rated hypochondriacal subjects as having more unrealistic fear of illness (hypochondriasis) and diagnosed psychiatric and functional somatic syndromes more frequently in hypochondriacal than in control subjects. Hypochondriacal subjects viewed their health as worse, had more health worries, and had more severe psychiatric symptoms than control subjects. They also reported poorer physical functioning and work performance, greater health care utilization, poorer response to medical treatment, and less satisfaction with the care received than controls.
Conclusions Results show that, although the diagnosis of hypochondriasis is rarely made, physician recognition is high. They also show that several indicators of internal and external validity of this diagnostic category exist. Findings suggest that if physicians are to reduce the functional impairment and nonproductive health care utilization of these patients, they will need to make the diagnosis of hypochondriasis and intervene appropriately. However, for this to occur, research demonstrating predictive validity and treatment responsiveness of the disorder will be required.
Author Affiliations
From the Departments of Psychiatry (Drs Noyes and Holt and Ms Fisher) and Internal Medicine (Drs Kathol, Phillips, and Suelzer), University of Iowa, College of Medicine, Iowa City.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial
Hedman et al.
Br. J. Psychiatry 2011;198:230-236.
ABSTRACT
| FULL TEXT
Health Anxiety and Disability Pension Award: The HUSK Study
Mykletun et al.
Psychosom. Med. 2009;71:353-360.
ABSTRACT
| FULL TEXT
Features of Hypochondriasis and Illness Worry in the General Population in Germany
Martin and Jacobi
Psychosom. Med. 2006;68:770-777.
ABSTRACT
| FULL TEXT
Cognitive Behavior Therapy for Hypochondriasis: A Randomized Controlled Trial
Barsky and Ahern
JAMA 2004;291:1464-1470.
ABSTRACT
| FULL TEXT
Test of an Interpersonal Model of Hypochondriasis
Noyes et al.
Psychosom. Med. 2003;65:292-300.
ABSTRACT
| FULL TEXT
Somatization and Medicalization in the Era of Managed Care
Barsky and Borus
JAMA 1995;274:1931-1934.
ABSTRACT
Psychiatric Screening in Geriatric Primary Care: Should It Be for Depression Alone?
Lish et al.
J Geriatr Psychiatry Neurol 1995;8:141-153.
ABSTRACT
|